Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-06

Clinical Trial Update: Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing measures of acute psychomotor agitation in people with schizophrenia and bipolar disorder has completed. The study is sponsored…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: BioXcel Therapeutics Inc | Conditions: Bipolar I Disorder, Bipolar II Disorder | Phase 2 | Status: COMPLETED